HRT FINANCIAL LP has completely liquidated its remaining holdings in Aditxt, Inc., concluding its relationship with the biotechnology firm. The institutional investor sold 2,833,463 shares of common stock on June 11, 2026, at a price of $0.014 per share. This transaction resulted in a total realized value of $39,668. According to a Form 4 filing submitted to the Securities and Exchange Commission on June 12, 2026, the disposal of these final shares means HRT FINANCIAL LP no longer maintains any ownership interest in Aditxt, Inc.
The divestiture occurs against a backdrop of severe market pressure for the company. Aditxt shares have experienced a 79% decline over the previous week, dropping to $0.01. This rapid depreciation has compressed the company's market capitalization to approximately $0.01 million. Broader performance metrics indicate even steeper losses, with the stock suffering a 99.99% decline year-to-date. Independent financial analysis from InvestingPro rates the company's financial health as "WEAK," highlighting significant operational vulnerabilities.
In response to these challenges, Aditxt has announced a series of strategic and operational adjustments. The company revealed that its subsidiary, Ignite Proteomics LLC, will become a publicly traded entity through a special purpose acquisition company transaction. This deal assigns an implied equity value of approximately $150 million to Ignite. To oversee these developments, Aditxt appointed Jeffrey M. Busch as interim CEO, a role he will hold concurrently with his position as CEO of Ignite Proteomics.
Further structural changes include the implementation of a 1-for-27 reverse stock split, effective May 18, 2026, following approval from stockholders. On the capital front, Aditxt disclosed a private placement of senior unsecured notes valued at $1.25 million. These notes carry an annual interest rate of 10% and are scheduled to mature on September 30, 2026.
Additionally, the company confirmed that it has regained compliance with Nasdaq listing standards. This compliance was verified through a letter from The Nasdaq Stock Market LLC, which cited the company's annual report showing stockholders' equity of $3,953,682. These actions collectively signal a period of intensive restructuring and financial stabilization efforts for Aditxt.